Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Javier Egea¹, Francisco López-Muñoz^{2

3}, Oscar Fernández-Capetillo^{4

5}, Russel J Reiter⁶, Alejandro Romero⁷

Affiliations

¹ Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de La Princesa, Madrid, Spain.
² Faculty of Health, University Camilo José Cela, Madrid, Spain.
³ Neuropsychopharmacology Unit, Hospital Doce de Octubre Research Institute (i+12), Madrid, Spain.
⁴ Genomic Instability Group, Spanish National Cancer Research Centre, Madrid, Spain.
⁵ Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
⁶ UTexas Health San Antonio, Long School of Medicine, San Antonio, TX, United States.
⁷ Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.

PMID: 35401215
PMCID: PMC8984144
DOI: 10.3389/fphar.2022.873197

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Javier Egea et al. Front Pharmacol. 2022.

. 2022 Mar 23:13:873197.

doi: 10.3389/fphar.2022.873197. eCollection 2022.

Authors

Javier Egea¹, Francisco López-Muñoz^{2

3}, Oscar Fernández-Capetillo^{4

5}, Russel J Reiter⁶, Alejandro Romero⁷

Affiliations

¹ Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de La Princesa, Madrid, Spain.
² Faculty of Health, University Camilo José Cela, Madrid, Spain.
³ Neuropsychopharmacology Unit, Hospital Doce de Octubre Research Institute (i+12), Madrid, Spain.
⁴ Genomic Instability Group, Spanish National Cancer Research Centre, Madrid, Spain.
⁵ Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
⁶ UTexas Health San Antonio, Long School of Medicine, San Antonio, TX, United States.
⁷ Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.

PMID: 35401215
PMCID: PMC8984144
DOI: 10.3389/fphar.2022.873197

No abstract available

Keywords: alkylating agents; cancer; drug safety; inflammation; melatonin; molecular therapeutics; oxidative stress; toxicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Cited by

Vanillic acid protects mortality and toxicity induced by N-ethyl-N-nitrosourea in mice; in vivo model of chronic lymphocytic leukemia.
Salimi A, Haddadi S, Khezri S, Asgari B, Pourgholi M. Salimi A, et al. Toxicol Rep. 2024 Mar 28;12:389-396. doi: 10.1016/j.toxrep.2024.03.013. eCollection 2024 Jun. Toxicol Rep. 2024. PMID: 38590344 Free PMC article.
Pre-mating exposure with hesperidin protects N-ethyl-N-nitrosourea-induced neurotoxicity and congenital abnormalities in next generation of mice as a model of glioma.
Khezri S, Azizian S, Salimi A. Khezri S, et al. J Mol Histol. 2024 Aug;55(4):627-636. doi: 10.1007/s10735-024-10218-0. Epub 2024 Jun 25. J Mol Histol. 2024. PMID: 38916842
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury.
Liu CJ, Wang LK, Tsai FM. Liu CJ, et al. Curr Issues Mol Biol. 2025 Mar 7;47(3):176. doi: 10.3390/cimb47030176. Curr Issues Mol Biol. 2025. PMID: 40136430 Free PMC article. Review.
Preparation of gallic acid-loaded chitosan nanoparticles and their chemoprotective effects on N-ethyl-N-nitrosourea-induced hepatotoxicity and mortality in rats.
Shirmard LR, Khezri S, Ahadzadeh S, Azadimoghaddam P, Azizian S, Salimi A. Shirmard LR, et al. J Mol Histol. 2024 Nov 25;56(1):1. doi: 10.1007/s10735-024-10280-8. J Mol Histol. 2024. PMID: 39585491
In Vivo Evidence of Melatonin's Protective Role in Alkylating-Agent-Induced Pulmonary Toxicity: A Systematic Review.
Sola E, Morales-García JA, López-Muñoz F, Ramos E, Romero A. Sola E, et al. Antioxidants (Basel). 2025 Jun 11;14(6):712. doi: 10.3390/antiox14060712. Antioxidants (Basel). 2025. PMID: 40563344 Free PMC article. Review.

References

1. Andersen L. P., Gögenur I., Rosenberg J., Reiter R. J. (2016). The Safety of Melatonin in Humans. Clin. Drug Investig. 36 (3), 169–175. 10.1007/s40261-015-0368-5 - DOI - PubMed
1. Bazwinsky-Wutschke I., Bieseke L., Mühlbauer E., Peschke E. (2014). Influence of Melatonin Receptor Signalling on Parameters Involved in Blood Glucose Regulation. J. Pineal Res. 56 (1), 82–96. 10.1111/jpi.12100 - DOI - PubMed
1. Capote-Moreno A., Ramos E., Egea J., López-Muñoz F., Gil-Martín E., Romero A. (2019). Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics. Cancers (Basel) 11 (11), 1712. 10.3390/cancers11111712 - DOI - PMC - PubMed
1. Cui Y., Ren L., Li B., Fang J., Zhai Y., He X., et al. (2017). Melatonin Relieves Busulfan-Induced Spermatogonial Stem Cell Apoptosis of Mouse Testis by Inhibiting Endoplasmic Reticulum Stress. Cell Physiol Biochem 44 (6), 2407–2421. 10.1159/000486165 - DOI - PubMed
1. De Araujo J. G., Serra L. S. M., Lauand L., Kückelhaus S. A. S., Sampaio A. L. L. (2019). Protective Effect of Melatonin on Cisplatin-Induced Ototoxicity in Rats. Anticancer Res. 39 (5), 2453–2458. 10.21873/anticanres.13364 - DOI - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Affiliations

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources